Publications by authors named "Laura Lilja"
Exp Hematol Oncol
March 2012
Article Synopsis
- The study investigates the role of oxidative stress markers and antioxidant enzymes in predicting outcomes for DLBCL patients treated with rituximab and CHOP-like therapy.
- Strong expression of certain markers, specifically 8-OHdG, thioredoxin (Trx), and glutamate-cysteine ligase (GCL), correlates with poorer patient prognosis, including progression-free survival and disease-specific survival.
- The findings suggest that measuring redox-regulating enzymes like Trx and GCL may be useful for evaluating prognosis in DLBCL in modern treatment settings.
